Similar Items: Diagnostic and therapeutic biomarker responses in HIV and tuberculosis co-infected patients
- DETERMINANTS OF TREATMENT ADHERENCE AMONG TUBERCULOSIS-INFECTED HIV PATIENTS IN CROSS RIVER STATE, NIGERIA
- And therapeutic outcomes lopinavir-ritonavir and a rifampicin containing anti-tuberculosis pharmacokinetics in children with tuberculosis/hiv co-infection treated with regimen
- Advancing tuberculosis treatment through pharmacometric modeling of drug exposure and biomarkers
- Combining different types of highly parallelised technology datasets for bioinformatic analysis in the context of biomarker discovery for tuberculosis disease and treatment response
- Evaluation of host biomarkers for early diagnosis of tuberculosis disease in children
- Investigating the role of respiratory co-infections and the nasopharyngeal microbiome in children with suspected pulmonary tuberculosis
Author: Dheda, Keertan
- Cigarette smoke and human pulmonary immune responses to mycobacteria
- Approaches to the diagnosis of smear-negative and sputum-scarce TB in South Africa
- Diagnostic and therapeutic biomarker responses in HIV and tuberculosis co-infected patients
- Utility of newer technologies for the diagnosis of active and latent tuberculosis
- Extensively drug resistant tuberculosis in South Africa
- Utility of newer and novel technologies for the diagnosis and treatment-monitoring of tuberculosis using different biological fluids